Literature DB >> 15601436

Principles of pharmacodynamics and their applications in veterinary pharmacology.

P Lees1, F M Cunningham, J Elliott.   

Abstract

Pharmacodynamics (PDs) is the science of drug action on the body or on microorganisms and other parasites within or on the body. It may be studied at many organizational levels--sub-molecular, molecular, cellular, tissue/organ and whole body--using in vivo, ex vivo and in vitro methods and utilizing a wide range of techniques. A few drugs owe their PD properties to some physico-chemical property or action and, in such cases, detailed molecular drug structure plays little or no role in the response elicited. For the great majority of drugs, however, action on the body is crucially dependent on chemical structure, so that a very small change, e.g. substitution of a proton by a methyl group, can markedly alter the potency of the drug, even to the point of loss of activity. In the late 19th century and first half of the 20th century recognition of these facts by Langley, Ehrlich, Dale, Clarke and others provided the foundation for the receptor site hypothesis of drug action. According to these early ideas the drug, in order to elicit its effect, had to first combine with a specific 'target molecule' on either the cell surface or an intracellular organelle. It was soon realized that the 'right' chemical structure was required for drug-target site interaction (and the subsequent pharmacological response). In addition, from this requirement, for specificity of chemical structure requirement, developed not only the modern science of pharmacology but also that of toxicology. In relation to drug actions on microbes and parasites, for example, the early work of Ehrlich led to the introduction of molecules selectively toxic for them and relatively safe for the animal host. In the whole animal drugs may act on many target molecules in many tissues. These actions may lead to primary responses which, in turn, may induce secondary responses, that may either enhance or diminish the primary response. Therefore, it is common to investigate drug pharmacodynamics (PDs) in the first instance at molecular, cellular and tissue levels in vitro, so that the primary effects can be better understood without interference from the complexities involved in whole animal studies. When a drug, hormone or neurotransmitter combines with a target molecule, it is described as a ligand. Ligands are classified into two groups, agonists (which initiate a chain of reactions leading, usually via the release or formation of secondary messengers, to the response) and antagonists (which fail to initiate the transduction pathways but nevertheless compete with agonists for occupancy of receptor sites and thereby inhibit their actions). The parameters which characterize drug receptor interaction are affinity, efficacy, potency and sensitivity, each of which can be elucidated quantitatively for a particular drug acting on a particular receptor in a particular tissue. The most fundamental objective of PDs is to use the derived numerical values for these parameters to classify and sub-classify receptors and to compare and classify drugs on the basis of their affinity, efficacy, potency and sensitivity. This review introduces and summarizes the principles of PDs and illustrates them with examples drawn from both basic and veterinary pharmacology. Drugs acting on adrenoceptors and cardiovascular, non-steroidal anti-inflammatory and antimicrobial drugs are considered briefly to provide a foundation for subsequent reviews in this issue which deal with pharmacokinetic (PK)-PD modelling and integration of these drug classes. Drug action on receptors has many features in common with enzyme kinetics and gas adsorption onto surfaces, as defined by Michaelis-Menten and Langmuir absorption equations, respectively. These and other derived equations are outlined in this review. There is, however, no single theory which adequately explains all aspects of drug-receptor interaction. The early 'occupation' and 'rate' theories each explain some, but not all, experimental observations. From these basic theories the operational model and the two-state theory have been developed. For a discussion of more advanced theories see Kenakin (1997).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15601436     DOI: 10.1111/j.1365-2885.2004.00620.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  9 in total

1.  Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.

Authors:  Omar Vesga; Maria Agudelo; Beatriz E Salazar; Carlos A Rodriguez; Andres F Zuluaga
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

2.  Triggered Nanoparticles as Therapeutics.

Authors:  Chang Soo Kim; Bradley Duncan; Brian Creran; Vincent M Rotello
Journal:  Nano Today       Date:  2013-08-01       Impact factor: 20.722

3.  The value of the post-captopril aldosterone/renin ratio for the diagnosis of primary aldosteronism and the influential factors: A meta-analysis.

Authors:  Qiao Xiang; Wen Wang; Tao Chen; Kai Yu; Qianrui Li; Tingting Zhang; Haoming Tian; Yan Ren
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

4.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

5.  Experimental therapeutic studies of Solanum aculeastrum Dunal. on Leishmania major infection in BALB/c mice.

Authors:  Linet T Laban; Christopher O Anjili; Joshua M Mutiso; Johnstone Ingonga; Samuel G Kiige; Mgala M Ngedzo; Michael M Gicheru
Journal:  Iran J Basic Med Sci       Date:  2015-01       Impact factor: 2.699

Review 6.  A Comprehensive Overview of Antibiotic Selection and the Factors Affecting It.

Authors:  Karan Patel; Sean Bunachita; Ank A Agarwal; Akshay Bhamidipati; Urvish K Patel
Journal:  Cureus       Date:  2021-03-16

Review 7.  Flavonoids Seen through the Energy Perspective.

Authors:  Zhengwen Li; Ming Zhang; Guido R M M Haenen; Lily Vervoort; Mohamed Moalin
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

Review 8.  Recent applications of quantitative systems pharmacology and machine learning models across diseases.

Authors:  Sara Sadat Aghamiri; Rada Amin; Tomáš Helikar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-20       Impact factor: 2.410

Review 9.  Chronopharmacodynamics of drugs in toxicological aspects: A short review for clinical pharmacists and pharmacy practitioners.

Authors:  Pinar Erkekoglu; Terken Baydar
Journal:  J Res Pharm Pract       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.